Fed. Circ. Provides Clarity On Patent Term Questions
In two decisions on Dec. 7, the Federal Circuit clarified the law of obviousness-type double patenting, or ODP, and provided certainty to biopharmaceutical patent owners. In Novartis AG v. Ezra Ventures...To view the full article, register now.
Already a subscriber? Click here to view full article